FDA Inspection 1235678 — John G. Sonnenberg, Ph.D.

John G. Sonnenberg, Ph.D. — FEI 3011266899

The FDA completed an inspection of John G. Sonnenberg, Ph.D. on April 2, 2024 in Chicago, IL. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
April 2, 2024
Fiscal Year
2024
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Chicago, IL (United States)

Additional Details

Clinical BA/BE